HCG

Acts as a stand-in for luteinizing hormone: it binds the LH receptor on the testes’ Leydig cells and drives them to produce testosterone, which also keeps the testes full-sized and functional rather than shrinking. Three real uses sit behind it — treating male hypogonadism and fertility, restoring or maintaining testicular function during and after testosterone or anabolic use (the dominant community reason people run it), and triggering ovulation in female fertility treatment. The honest split: the endocrine and fertility medicine is genuinely established; the exact TRT-adjunct dosing people run alongside testosterone is extrapolated from that, not separately validated.

The reason it matters to anyone on testosterone is the feedback loop. Inject testosterone and the brain reads the blood as ‘plenty here,’ stops sending LH, and the testes — no longer getting the signal — quit producing and shrink. HCG steps in one rung lower than the brain: it ignores that shutdown and pokes the testes directly, so they keep working even while the upstream signal is silenced. That’s why it’s the classic answer to two of the most-asked questions in the space — testicular shrinkage on TRT and fertility while on testosterone. It also has a feature its smaller cousins lack: a long half-life, because the sugar chains hung off the protein shield it from rapid breakdown.

HCG and LH share the same receptor (LHCGR) on testicular Leydig cells; HCG binds it and triggers the same downstream cascade — cAMP/PKA signaling that drives the enzymes converting cholesterol into testosterone, right inside the testis. Because the signal lands below the pituitary, it bypasses the hypothalamic–pituitary brake entirely: it works even when exogenous testosterone has shut LH off. In women the same LH-mimicry is used as a one-time surge to drive final egg maturation and ovulation. The catch baked into the mechanism: it’s pushing the testosterone factory, and that factory’s aromatase enzyme also converts a share of that testosterone into estradiol — so harder stimulation means more estrogen, not just more testosterone.

The dominant, predictable one is estrogen conversion: because HCG ramps testosterone production at the source, aromatase turns a chunk of it into estradiol, which is why high estrogen, water retention, and gynecomastia risk are the recurring complaints — some people manage it with an estrogen-aware approach under guidance. Other endocrine effects: mood changes, acne, and over the long term the possibility of reduced testicular sensitivity from sustained stimulation. In female fertility use the named clinical risk is ovarian hyperstimulation syndrome. And the loudest honesty flag here has nothing to do with the legitimate uses: HCG has been heavily marketed for weight loss, and that use is discredited. It does NOT cause fat loss — approved prescription HCG is required to carry an explicit label statement that it has not been shown to be effective for weight loss, and regulators have acted against the over-the-counter “homeopathic” HCG diet products outright. Treat any fat-loss claim as a red flag.

In the community it’s almost never run alone — its whole role is as the support compound that runs alongside testosterone, keeping the testes online while exogenous testosterone shuts the natural signal down. The other genuine pairing is in clinical fertility work, where it’s combined with FSH (or an FSH-like agent like HMG) to drive full sperm production in men whose own gonadotropins are absent — HCG covers the LH/testosterone side, FSH covers the sperm-maturation side. Because it raises estrogen, an estrogen-management strategy is frequently part of the conversation. It is not a fat-loss tool and shouldn’t be stacked as one.